SCHEMBL2931602

SCHEMBL2931602

O=C(O)Nc1ccc(Oc2ccnc3nc(C(F)(F)F)c(=O)[nH]c23)c2ccccc12

nearest known ligand 0.73

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
BRAF P15056 20/20 0.73
SRC P12931 1/20 0.45
MAPK12 P53778 1/20 0.45
MAPK14 Q16539 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3763657 0.88 BRAF (0.68) BRAF
SCHEMBL2928658 0.86 BRAF (0.69) BRAFSRCMAPK12MAPK14
SCHEMBL2933258 0.86 BRAF (0.73) BRAFSRCMAPK12MAPK14
SCHEMBL2926335 0.85 BRAF (0.68) BRAFSRCMAPK12MAPK14
SCHEMBL2934892 0.85 BRAF (1.00) BRAF
SCHEMBL2935898 0.82 BRAF (0.59) BRAF
SCHEMBL2931611 0.80 BRAF (0.66) BRAFSRCMAPK12MAPK14
SCHEMBL3762215 0.78 BRAF (0.65) BRAFSRCMAPK12MAPK14
SCHEMBL4464984 0.78 BRAF (0.67) BRAFSRCMAPK12MAPK14
SCHEMBL2934109 0.77 BRAF (1.00) BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2229391-A1 PYRIDO[2,3-B]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE Cancer Research Technology Limited (GB) 2010-09-22 EP disclosed
WO-2009077766-A1 PYRIDO[2,3-B]PYRAZINE-8-SUBSTITUTED COMPOUNDS AND THEIR USE CANCER RESEARCH TECHNOLOGY LIMITED (GB) 2009-06-25 WO disclosed